避孕藥具市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Contraceptives Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年09月11日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球避孕藥具市場價值為230 億美元，由於人們越來越重視預防性傳染病(STD) 以及對懷孕創新技術的認知不斷增強，預計2024 年至2032 年期間複合年成長率將達到6.3%預防。隨著公共衛生運動強調安全性行為的重要性，越來越多的人正在尋求有效的避孕方法，以降低性傳染病和意外懷孕的風險。此外，避孕技術的進步，例如非侵入性方法和個人化解決方案，正在吸引消費者，進一步促進市場成長，並擴大獲得有效避孕選擇的機會。整個避孕藥具產業根據產品、年齡層、配銷通路和地區進行分類。

由於對子宮內避孕器 (IUD) 和植入式避孕器等持久且高效的選擇的需求不斷增加，2023 年該器械領域的銷售額將達到 160 億美元。這些方法在預防意外懷孕方面的成功率更高，這促使他們比傳統替代方法更受青睞。此外，科技的進步和生殖健康意識的提高進一步促進了避孕器具的採用，鞏固了與其他形式的避孕器具相比其在市場上的主導地位。在藥房、藥局和線上平台上產品供應不斷增加的推動下，到 2032 年，零售領域將達到 183 億美元。

便利性，加上消費者對便利訪問的偏好，推動了這一領域的成長。零售通路提供多種避孕選擇，讓消費者可以選擇最適合自己需求的產品。此外，促銷活動和健康活動正在提高消費者的意識，從而加強零售部門在避孕藥具市場中的地位。由於該地區強大的醫療基礎設施、較高的計劃生育意識以及先進避孕方法的廣泛使用，北美避孕藥具行業到 2023 年將達到 75 億美元，到 2032 年複合年成長率將達到 4%。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	230億美元
預測值	400 億美元
複合年成長率	6.3%

政府支持生殖健康的舉措，以及人們對長效可逆避孕藥 (LARC) 的日益青睞，進一步推動了市場成長。此外，領先製造商和完善的分銷網路的存在增強了避孕產品的獲取。北美強勁的需求和先進的醫療保健系統使其成為全球避孕藥市場的主要貢獻者。

產業生態系統分析
產業影響力
- 成長動力
  - 已開發國家有利的監管環境
  - 越來越傾向於計劃性延遲妊娠
  - 發展中經濟體的避孕需求未被滿足
  - 性傳染病（STD）盛行率不斷上升
- 產業陷阱與挑戰
  - 避孕藥的不良反應
成長潛力分析
監管環境
報銷場景
定價趨勢
消費者行為分析
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
裝置
- 保險套
  - 男性
  - 女性
- 子宮內避孕器
  - 荷爾蒙子宮內避孕器
  - 含銅子宮內避孕器
- 陰道環
- 皮下植入物
- 隔膜
- 避孕海綿
藥品
- 口服避孕藥
- 注射避孕藥
- 外用避孕藥

第 6 章：市場估計與預測：按年齡分類，2021 - 2032

主要趨勢
15 - 44 歲
44歲以上

第 7 章：市場估計與預測：按配銷通路，2021 - 2032 年

主要趨勢
零售藥局
醫院藥房
線上通路
其他分銷管道

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Afaxys, Inc.
Agile Therapeutics
Amneal Pharmaceuticals
Bayer AG
Church & Dwight Co., Inc.
Cooper Companies
Evofem Biosciences
HRA Pharma
Maxwellia Ltd
Mayer Laboratories, Inc.
Mithra Pharmaceuticals
Organon & Co.
Pfizer, Inc.
Reckitt Benckiser Group PLC
TherapeuticsMD, Inc.
Veru, Inc.

簡介目錄

Product Code: 430

The Global Contraceptives Market was valued at USD 23 billion in 2023 and is estimated to expand at a 6.3% CAGR between 2024 and 2032, spurred by the increasing emphasis on the prevention of sexually transmitted diseases (STDs) and growing awareness of innovative technologies for pregnancy prevention. As public health campaigns highlight the importance of safe sexual practices, more individuals are seeking effective contraceptive methods to reduce the risk of STDs and unintended pregnancies. Also, advancements in contraceptive technologies, such as non-invasive methods and personalized solutions, are attracting consumers, further boosting market growth, and broadening access to effective contraceptive options. The overall contraceptives industry is segregated based on product, age group, distribution channel, and region.

The devices segment achieved USD 16 billion in 2023 due to the increasing demand for long-lasting and highly effective options like intrauterine devices (IUDs) and contraceptive implants. These methods offer a higher success rate in preventing unintended pregnancies, which drives their preference over traditional alternatives. Additionally, advancements in technology and growing awareness about reproductive health further boost the adoption of contraceptive devices, solidifying their dominance in the market compared to other forms of contraception. The retail segment will establish USD 18.3 billion by 2032, driven by the increasing availability of products in pharmacies, drugstores, and online platforms.

Convenience, coupled with consumer preference for easy access, drives growth in this segment. Retail channels provide a variety of contraceptive options, allowing consumers to choose products that best suit their needs. Furthermore, promotional activities and health campaigns are enhancing consumer awareness, thereby reinforcing the retail segment's position in the contraceptives market. North America contraceptives industry held a USD 7.5 billion in 2023 and will experience a 4% CAGR through 2032, owing to the region's strong healthcare infrastructure, high awareness of family planning, and widespread use of advanced contraceptive methods.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$23 Billion
Forecast Value	$40 Billion
CAGR	6.3%

Government initiatives supporting reproductive health, along with a growing preference for long-acting reversible contraceptives (LARCs), further propel market growth. Besides, the presence of leading manufacturers and well-established distribution networks enhances access to contraceptive products. North America's robust demand and advanced healthcare system make it the key contributor to the global contraceptives market.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Favourable regulatory scenario in developed nations
  - 3.2.1.2 Growing inclination towards planned delayed pregnancy
  - 3.2.1.3 High unmet contraceptive needs in developing economies
  - 3.2.1.4 Growing prevalence of sexually transmitted diseases (STD)
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Adverse effects of contraceptive drugs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Pricing trends
3.7 Consumer behavior analysis
3.8 Technology landscape
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Devices
- 5.2.1 Condoms
  - 5.2.1.1 Male
  - 5.2.1.2 Female
- 5.2.2 Intra-uterine devices
  - 5.2.2.1 Hormonal IUD
  - 5.2.2.2 Copper IUD
- 5.2.3 Vaginal rings
- 5.2.4 Subdermal implants
- 5.2.5 Diaphragms
- 5.2.6 Contraceptive sponges
5.3 Drugs
- 5.3.1 Oral contraceptive pills
- 5.3.2 Injectable contraceptives
- 5.3.3 Topical contraceptives

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 15 - 44 years
6.3 Above 44 years

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Retail pharmacies
7.3 Hospital pharmacies
7.4 Online channels
7.5 Other distribution channels

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa